Literature DB >> 1313572

Cap-specific mRNA (nucleoside-O2'-)-methyltransferase and poly(A) polymerase stimulatory activities of vaccinia virus are mediated by a single protein.

B S Schnierle1, P D Gershon, B Moss.   

Abstract

The vaccinia virus gene for S-adenosyl-L-methionine:mRNA (nucleoside-O2'-)-methyltransferase, an enzyme required for the formation of the 5' cap structure of mRNA, was identified. Protein sequence analysis revealed that this cap-specific methyltransferase is derived from the same open reading frame as that previously shown to encode VP39, a Mr 39,000 dissociable subunit of poly(A) polymerase that stimulates the formation of long poly(A) tails. Consistent with this finding, methyltransferase activity was associated with the heterodimeric poly(A) polymerase, which is composed of VP55 and VP39 subunits, as well as with monomeric VP39 protein isolated from vaccinia virions. In addition, cap-specific nucleoside-O2'-methyltransferase activity is associated with recombinant VP39, which was purified to near homogeneity from mammalian cells. From these data, we concluded that the same protein functions as a methyltransferase and a poly(A) polymerase stimulatory factor to modify the 5' and 3' ends of mRNA, respectively.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1313572      PMCID: PMC48770          DOI: 10.1073/pnas.89.7.2897

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Cytosine-specific type II DNA methyltransferases. A conserved enzyme core with variable target-recognizing domains.

Authors:  R Lauster; T A Trautner; M Noyer-Weidner
Journal:  J Mol Biol       Date:  1989-03-20       Impact factor: 5.469

2.  Transmethylation and transguanylylation in 5'-RNA capping system isolated from rat liver nuclei.

Authors:  K Mizumoto; F Lipmann
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

3.  Internal amino acid sequence analysis of proteins separated by one- or two-dimensional gel electrophoresis after in situ protease digestion on nitrocellulose.

Authors:  R H Aebersold; J Leavitt; R A Saavedra; L E Hood; S B Kent
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

4.  The second-largest subunit of the poxvirus RNA polymerase is similar to the corresponding subunits of procaryotic and eucaryotic RNA polymerases.

Authors:  D D Patel; D J Pickup
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

Review 5.  5'-terminal cap structure in eucaryotic messenger ribonucleic acids.

Authors:  A K Banerjee
Journal:  Microbiol Rev       Date:  1980-06

6.  Post-transcriptional modifications of mRNA. Purification and characterization of cap I and cap II RNA (nucleoside-2'-)-methyltransferases from HeLa cells.

Authors:  S R Langberg; B Moss
Journal:  J Biol Chem       Date:  1981-10-10       Impact factor: 5.157

7.  Purification of mRNA guanylyltransferase and mRNA (guanine-7-) methyltransferase from vaccinia virions.

Authors:  S A Martin; E Paoletti; B Moss
Journal:  J Biol Chem       Date:  1975-12-25       Impact factor: 5.157

8.  Modification of the 5' terminus of mRNA by an RNA (guanine-7-)-methyltransferase from HeLa cells.

Authors:  M J Ensinger; B Moss
Journal:  J Biol Chem       Date:  1976-09-10       Impact factor: 5.157

9.  Purification and characterization of a transcription termination factor from vaccinia virions.

Authors:  S Shuman; S S Broyles; B Moss
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

10.  mRNA(nucleoside-2'-)-methyltransferase from vaccinia virus. Characteristics and substrate specificity.

Authors:  E Barbosa; B Moss
Journal:  J Biol Chem       Date:  1978-11-10       Impact factor: 5.157

View more
  41 in total

1.  Autographa californica nucleopolyhedrovirus orf69 encodes an RNA cap (nucleoside-2'-O)-methyltransferase.

Authors:  Xiaofeng Wu; Linda A Guarino
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

Review 2.  Enzymology of RNA cap synthesis.

Authors:  Agnidipta Ghosh; Christopher D Lima
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-25       Impact factor: 9.957

3.  Structural insights into the mechanism and evolution of the vaccinia virus mRNA cap N7 methyl-transferase.

Authors:  Marcos De la Peña; Otto J P Kyrieleis; Stephen Cusack
Journal:  EMBO J       Date:  2007-11-08       Impact factor: 11.598

Review 4.  RNA-specific ribonucleotidyl transferases.

Authors:  Georges Martin; Walter Keller
Journal:  RNA       Date:  2007-09-13       Impact factor: 4.942

5.  The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure.

Authors:  Moheshwarnath Issur; Brian J Geiss; Isabelle Bougie; Frédéric Picard-Jean; Simon Despins; Joannie Mayette; Sarah E Hobdey; Martin Bisaillon
Journal:  RNA       Date:  2009-10-22       Impact factor: 4.942

6.  A protein related to the vaccinia virus cap-specific methyltransferase VP39 is involved in cap 4 modification in Trypanosoma brucei.

Authors:  George K Arhin; Hongjie Li; Elisabetta Ullu; Christian Tschudi
Journal:  RNA       Date:  2005-11-21       Impact factor: 4.942

7.  The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression.

Authors:  G R Kovacs; B Moss
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

8.  A new vaccinia virus intermediate transcription factor.

Authors:  P Sanz; B Moss
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

9.  Cap ribose methylation of c-mos mRNA stimulates translation and oocyte maturation in Xenopus laevis.

Authors:  H Kuge; G G Brownlee; P D Gershon; J D Richter
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

10.  In vitro reconstitution of SARS-coronavirus mRNA cap methylation.

Authors:  Mickaël Bouvet; Claire Debarnot; Isabelle Imbert; Barbara Selisko; Eric J Snijder; Bruno Canard; Etienne Decroly
Journal:  PLoS Pathog       Date:  2010-04-22       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.